| | ||||||||
| "anti diabetes" | ||||||||
| NEWS | ||||||||
Keefe, Bruyette Initiates Coverage of First Data With Outperform Rating, $15 PT (NSE:FDC) The Company's therapeutic divisions include anti-infectives, vitamins/minerals/dietary supplements, cardiac, anti-diabetes, respiratory, gynecology, ...
| ||||||||
| You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
| Send Feedback |
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.